SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001628280-24-001074
Filing Date
2024-01-10
Accepted
2024-01-10 19:14:35
Documents
1
Period of Report
2024-01-09

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1704932063.html 4  
1 FORM 4 wk-form4_1704932063.xml 4 5270
  Complete submission text file 0001628280-24-001074.txt   6818
Mailing Address 3515 LYMAN BOULEVARD CHASKA MN 55318
Business Address 3515 LYMAN BOULEVARD CHASKA MN 55318 9523684300
LIFECORE BIOMEDICAL, INC. \DE\ (Issuer) CIK: 0001005286 (see all company filings)

IRS No.: 943025618 | State of Incorp.: DE | Fiscal Year End: 0528
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O ANEBULO PHARMACEUTICALS, INC. 1415 RANCH ROAD 620 SOUTH, SUITE 201 LAKEWAY TX 78734
Business Address
Calloway Nathaniel (Reporting) CIK: 0001952771 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-27446 | Film No.: 24527655